PE25198A1 - Nuevos taxoides, su preparacion y las composiciones farmaceuticas que las contienen - Google Patents

Nuevos taxoides, su preparacion y las composiciones farmaceuticas que las contienen

Info

Publication number
PE25198A1
PE25198A1 PE1996000871A PE00087196A PE25198A1 PE 25198 A1 PE25198 A1 PE 25198A1 PE 1996000871 A PE1996000871 A PE 1996000871A PE 00087196 A PE00087196 A PE 00087196A PE 25198 A1 PE25198 A1 PE 25198A1
Authority
PE
Peru
Prior art keywords
formula
saturated
phenyl
hydroxy
preparation
Prior art date
Application number
PE1996000871A
Other languages
English (en)
Spanish (es)
Inventor
Herve Bouchard
Alain Commercom
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of PE25198A1 publication Critical patent/PE25198A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PE1996000871A 1995-12-22 1996-12-04 Nuevos taxoides, su preparacion y las composiciones farmaceuticas que las contienen PE25198A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9515379A FR2742751B1 (fr) 1995-12-22 1995-12-22 Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
PE25198A1 true PE25198A1 (es) 1998-05-10

Family

ID=9485871

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1996000871A PE25198A1 (es) 1995-12-22 1996-12-04 Nuevos taxoides, su preparacion y las composiciones farmaceuticas que las contienen

Country Status (40)

Country Link
US (1) US5728849A (cg-RX-API-DMAC10.html)
EP (1) EP0876362B1 (cg-RX-API-DMAC10.html)
JP (1) JP3953106B2 (cg-RX-API-DMAC10.html)
KR (1) KR100500351B1 (cg-RX-API-DMAC10.html)
CN (1) CN1103766C (cg-RX-API-DMAC10.html)
AR (1) AR005197A1 (cg-RX-API-DMAC10.html)
AT (1) ATE250593T1 (cg-RX-API-DMAC10.html)
AU (1) AU712597B2 (cg-RX-API-DMAC10.html)
BG (1) BG63204B1 (cg-RX-API-DMAC10.html)
BR (1) BR9612135A (cg-RX-API-DMAC10.html)
CA (1) CA2238884C (cg-RX-API-DMAC10.html)
CO (1) CO4520184A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ294972B6 (cg-RX-API-DMAC10.html)
DE (1) DE69630145T2 (cg-RX-API-DMAC10.html)
DK (1) DK0876362T3 (cg-RX-API-DMAC10.html)
DZ (1) DZ2149A1 (cg-RX-API-DMAC10.html)
EA (1) EA001533B1 (cg-RX-API-DMAC10.html)
ES (1) ES2202490T3 (cg-RX-API-DMAC10.html)
FR (1) FR2742751B1 (cg-RX-API-DMAC10.html)
HU (1) HU225032B1 (cg-RX-API-DMAC10.html)
IL (1) IL124994A (cg-RX-API-DMAC10.html)
IN (4) IN186768B (cg-RX-API-DMAC10.html)
MA (1) MA26412A1 (cg-RX-API-DMAC10.html)
MX (1) MX9804688A (cg-RX-API-DMAC10.html)
MY (1) MY113934A (cg-RX-API-DMAC10.html)
NO (1) NO317358B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ324337A (cg-RX-API-DMAC10.html)
OA (1) OA10700A (cg-RX-API-DMAC10.html)
PE (1) PE25198A1 (cg-RX-API-DMAC10.html)
PL (1) PL189311B1 (cg-RX-API-DMAC10.html)
PT (1) PT876362E (cg-RX-API-DMAC10.html)
RO (1) RO116194B1 (cg-RX-API-DMAC10.html)
SK (1) SK282835B6 (cg-RX-API-DMAC10.html)
TN (1) TNSN96169A1 (cg-RX-API-DMAC10.html)
TR (1) TR199801179T2 (cg-RX-API-DMAC10.html)
TW (1) TW371659B (cg-RX-API-DMAC10.html)
UA (1) UA48205C2 (cg-RX-API-DMAC10.html)
UY (1) UY24386A1 (cg-RX-API-DMAC10.html)
WO (1) WO1997023473A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA9610737B (cg-RX-API-DMAC10.html)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
CZ20013405A3 (cs) 2000-02-02 2002-03-13 Florida State University Research Foundation, Inc. C10 karbonátem substituované taxany jako protinádorová činidla
SK286975B6 (sk) * 2001-02-24 2009-08-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xantínové deriváty, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US20080107721A1 (en) * 2003-05-20 2008-05-08 Jonathan Lewis Combination Chemotherapy Comprising A Liposomal Platinum Complex
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
EP1669358A1 (en) * 2004-12-07 2006-06-14 Aventis Pharma S.A. Cytotoxic agents comprising new taxanes
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
KR101541791B1 (ko) * 2006-05-04 2015-08-04 베링거 인겔하임 인터내셔날 게엠베하 다형태
US20080207743A1 (en) * 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment
AU2008290582B2 (en) * 2007-08-17 2014-08-14 Boehringer Ingelheim International Gmbh Purin derivatives for use in the treatment of fab-related diseases
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
KR20200118243A (ko) 2008-08-06 2020-10-14 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
US20110190322A1 (en) * 2008-08-14 2011-08-04 Boehringer Ingelheim International Gmbh Purin derivatives for use in the treatment of fab-related diseases
BRPI0919288A2 (pt) 2008-09-10 2015-12-15 Boehring Ingelheim Internat Gmbh teriapia de combinação para tratamento de diabetes e condições relacionadas.
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
KR20110103968A (ko) 2008-12-23 2011-09-21 베링거 인겔하임 인터내셔날 게엠베하 유기 화합물의 염 형태
TW201036975A (en) 2009-01-07 2010-10-16 Boehringer Ingelheim Int Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
KR20240090632A (ko) 2009-11-27 2024-06-21 베링거 인겔하임 인터내셔날 게엠베하 리나글립틴과 같은 dpp-iv 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
ES2935300T3 (es) 2010-05-05 2023-03-03 Boehringer Ingelheim Int Combiterapia
MX2012014247A (es) 2010-06-24 2013-01-18 Boehringer Ingelheim Int Terapia para la diabetes.
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
ES2934843T3 (es) 2011-07-15 2023-02-27 Boehringer Ingelheim Int Derivado de quinazolina dimérico sustituido, su preparación y su uso en composiciones farmacéuticas para el tratamiento de la diabetes de tipo I y II
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US20130303462A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
EP4151218A1 (en) 2012-05-14 2023-03-22 Boehringer Ingelheim International GmbH Linagliptin, a xanthine derivative as dpp-4 inhibitor, for use in the treatment of sirs and/or sepsis
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
CA2891280C (en) 2012-11-24 2018-03-20 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
FR3010839B1 (fr) * 2013-09-17 2017-04-21 Schneider Electric Ind Sas Dispositif de raccordement electrique d'au moins un conducteur dans une borne appartenant a un appareil electrique
US10464955B2 (en) 2014-02-28 2019-11-05 Hangzhou Dac Biotech Co., Ltd. Charged linkers and their uses for conjugation
EP3110449B1 (en) 2014-02-28 2023-06-28 Boehringer Ingelheim International GmbH Medical use of a dpp-4 inhibitor
EP4678240A2 (en) 2015-07-12 2026-01-14 Hangzhou Dac Biotech Co., Ltd. Bridge linkers for conjugation of cell-binding molecules
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
WO2017211979A1 (en) 2016-06-10 2017-12-14 Boehringer Ingelheim International Gmbh Combinations of linagliptin and metformin
MX2019005583A (es) 2016-11-14 2019-10-21 Hangzhou Dac Biotech Co Ltd Vinculantes de conjugacion, conjugados de molecula de union a celulas que contienen los vinculantes, metodos de creacion y usos de dichos conjugados con los vinculantes.
EP4426727A2 (en) 2021-11-03 2024-09-11 Hangzhou Dac Biotech Co., Ltd. Specific conjugation of an antibody

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2017724C1 (ru) * 1990-07-12 1994-08-15 Дзе Юниверсити оф Канзас Способ получения производных таксола
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
FR2678930B1 (fr) * 1991-07-10 1995-01-13 Rhone Poulenc Rorer Sa Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii.
RU2059631C1 (ru) * 1991-11-29 1996-05-10 Дзе Юниверсити оф Канзас Производные таксола и фармацевтическая композиция, обладающая противоопухолевой активностью
AU672006B2 (en) * 1992-04-17 1996-09-19 Abbott Laboratories Taxol derivatives
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
MX9307777A (es) * 1992-12-15 1994-07-29 Upjohn Co 7-HALO-Y 7ß, 8ß-METANO-TAXOLES, USO ANTINEOPLASTICO Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.

Also Published As

Publication number Publication date
ES2202490T3 (es) 2004-04-01
EA001533B1 (ru) 2001-04-23
CA2238884C (fr) 2007-02-06
BR9612135A (pt) 1999-07-13
NO982580L (no) 1998-06-05
CA2238884A1 (fr) 1997-07-03
IN188680B (cg-RX-API-DMAC10.html) 2002-10-26
DE69630145D1 (de) 2003-10-30
IL124994A (en) 2000-12-06
IN188469B (cg-RX-API-DMAC10.html) 2002-09-28
BG63204B1 (bg) 2001-06-29
EP0876362A1 (fr) 1998-11-11
HUP9904046A1 (hu) 2001-04-28
ATE250593T1 (de) 2003-10-15
NZ324337A (en) 2000-03-27
MA26412A1 (fr) 2004-12-20
AU712597B2 (en) 1999-11-11
AR005197A1 (es) 1999-04-14
NO982580D0 (no) 1998-06-05
PL327405A1 (en) 1998-12-07
FR2742751A1 (fr) 1997-06-27
SK85398A3 (en) 1998-11-04
TW371659B (en) 1999-10-11
MY113934A (en) 2002-06-29
BG102569A (en) 1999-04-30
KR19990076680A (ko) 1999-10-15
IN186768B (cg-RX-API-DMAC10.html) 2001-11-03
MX9804688A (es) 1998-10-31
ZA9610737B (en) 1997-06-27
DE69630145T2 (de) 2004-07-15
DK0876362T3 (da) 2004-02-02
UA48205C2 (uk) 2002-08-15
RO116194B1 (ro) 2000-11-30
OA10700A (fr) 2002-11-27
US5728849A (en) 1998-03-17
EP0876362B1 (fr) 2003-09-24
EA199800588A1 (ru) 1998-12-24
IL124994A0 (en) 1999-01-26
IN188470B (cg-RX-API-DMAC10.html) 2002-09-28
KR100500351B1 (ko) 2005-12-21
CZ294972B6 (cs) 2005-04-13
HK1017895A1 (en) 1999-12-03
NO317358B1 (no) 2004-10-18
TNSN96169A1 (fr) 2005-03-15
PL189311B1 (pl) 2005-07-29
HUP9904046A3 (en) 2001-08-28
PT876362E (pt) 2004-02-27
UY24386A1 (es) 2001-08-27
JP2000502671A (ja) 2000-03-07
WO1997023473A1 (fr) 1997-07-03
CN1103766C (zh) 2003-03-26
SK282835B6 (sk) 2002-12-03
HU225032B1 (en) 2006-05-29
CN1205697A (zh) 1999-01-20
DZ2149A1 (fr) 2002-10-23
JP3953106B2 (ja) 2007-08-08
FR2742751B1 (fr) 1998-01-30
CZ196198A3 (cs) 1998-09-16
TR199801179T2 (xx) 1998-10-21
CO4520184A1 (es) 1997-10-15
AU1180997A (en) 1997-07-17

Similar Documents

Publication Publication Date Title
PE25198A1 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que las contienen
NL960021I1 (nl) Nieuwe trifenylalkaan en alkeenderivaten en de bereiding en toepassing daarvan.
ES8400415A1 (es) "un procedimiento para la preparacion de derivados de 2,4-diaminoquinazolina".
PE51097A1 (es) Nuevos taxoides, su preparacion y composiciones farmaceuticas que los contienen
ATE47997T1 (de) Substituierte imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung.
AR002240A1 (es) Derivado de 2,4-oxazolidinadiona, composicion farmaceutica que lo comprende y metodo de preparacion del mismo.
ES8507479A1 (es) Un metodo para producir un derivado de amina
AR018186A1 (es) Compuestos de carbazoly de 1,2,3,4-tetrahidrocarbazol sustituidos, utiles como inhibidores de la liberacion de acidos grasos mediada por spla2,procedimiento para prepararlos; compuestos intermediarios de aplicacion en dichos procedimientos; composiciones farmaceuticas que comprenden dichos compuesto
AR044400A1 (es) Procesos para la preparacion de derivados de pirimidina
AR002690A1 (es) Derivado de bencimidazol o sales del mismo, composicion farmaceutica, agente inmunosupresor y agente antiinflamatorio que lo contienen yprocedimientos para preparar dicho derivado.
EA200600490A1 (ru) Новые сульфонамиды в качестве средств защиты растений
ES8702403A1 (es) Un procedimiento para la preparacion de nuevas n-((4-piperidinil)alquil)oxazol y tiazolaminas condensadas biciclicas sustituidas
DE3769404D1 (de) Phenolische benzthiazolderivate und ihre verwendung als korrosionsinhibitoren.
ES8707925A1 (es) Un procedimiento para la preparacion de derivados de aminofenol
ES8305755A1 (es) Procedimiento para preparar derivados de pirimidona.
ES2106936T3 (es) Derivados de carbazolona y procedimientos para su preparacion.
ES8604196A1 (es) Procedimiento para la preparacion de n-piridilindoles
ES8706148A1 (es) Un procedimiento para preparar nuevos derivados de carbapenem.
AR006876A1 (es) Procedimiento e intermedios para preparar el compuesto {2-(2-[1,2,4]- triazol-3-ilmetil)-1,2,3,4-tetrahidroisoquinolin-6-il} amida del acido 4'-trifluorometilbifenil-2-carboxilico
ES2016017A6 (es) Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico.
AR007291A1 (es) Nuevos derivados de 10,11-dihidro-10-oxo-5h-dibenz/b, f/azepina-5-carboxamida, metodo de preparacion y su uso en la preparacion de una composicion farmaceutica
ES500810A0 (es) Procedimiento de preparacion de aminoalcoxipirazoles
BR9709791A (pt) Intermediários para a síntese de oligonucleotíedeos
IE41070B1 (en) Amidino-hydrazone derivatives of benzocycloalkanones
KR910004632A (ko) 신규한 1-옥사-2-옥소-8-아자스피로[4,5]데칸 유도체와 그들을 포함하는 약제학적 조성물 및 그 제조방법

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed